Skin Biopsy as a Diagnostic Tool for Synucleinopathies

Area of Science:

• Neurology
• Pathology
• Biomarker Discovery

Background:

• Skin biopsies are increasingly recognized as a viable source for detecting alpha-synuclein (αSN).
• Alpha-synuclein deposition in skin is characteristic of synucleinopathies.
• Skin biopsies aid in histopathological diagnosis and research into αSN deposit characteristics.

Purpose of the Study:

• To review factors influencing the sensitivity, specificity, and feasibility of skin biopsies for detecting dermal αSN.
• To assess the potential of skin biopsy as a clinical diagnostic tool for synucleinopathies.

Main Methods:

• Review of studies published in the last decade focusing on αSN detection in skin biopsies.
• Analysis of diagnostic performance metrics including sensitivity and specificity.
• Evaluation of technical feasibility for clinical application.

Main Results:

• Skin biopsies demonstrate high sensitivity (>80%) and specificity (approaching 100%) for detecting αSN.
• The potential for skin biopsy to become a preferred clinical diagnostic tool is significant.
• Various factors influence the diagnostic accuracy and practicality of the procedure.

Conclusions:

• Skin biopsy is a highly sensitive and specific method for diagnosing synucleinopathies.
• The technical feasibility supports its adoption as a clinical diagnostic tool.
• Further understanding of influencing factors can optimize its use in clinical practice.